Plexus (NASDAQ: PLXS) executive files to sell 4,841 shares

Rhea-AI Filing Summary

Plexus Corp. insider Patrick Jermain has filed a Form 144 notice to sell up to 4,841 shares of Plexus common stock. The planned sale, with an aggregate market value of $987,612.41, is to be executed through Morgan Stanley Smith Barney LLC on or around February 3, 2026 on the NASDAQ market. The shares come from restricted stock acquired on January 25, 2019 and performance shares acquired on November 13, 2024. Over the prior three months, Jermain also sold 2,000 Plexus common shares for gross proceeds of $287,070.00.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4841	987612.41	26774415	02/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/25/2019	Restricted Stock	Issuer			2694	01/25/2019	Not Applicable
Common	11/13/2024	Performance Shares	Issuer			2147	11/13/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PATRICK JERMAIN One Plexus Way Neenah WI 54956	Common	11/11/2025	2000	287070.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing by Plexus (PLXS) insider Patrick Jermain disclose?

The filing discloses that insider Patrick Jermain plans to sell up to 4,841 Plexus common shares under Rule 144. The planned sale has an aggregate market value of $987,612.41 and is expected to be executed on the NASDAQ through Morgan Stanley Smith Barney LLC.

How many Plexus (PLXS) shares is Patrick Jermain planning to sell and at what value?

Patrick Jermain plans to sell 4,841 shares of Plexus common stock with an aggregate market value of $987,612.41. These shares are to be sold through Morgan Stanley Smith Barney LLC in a Rule 144 transaction, with trading expected on the NASDAQ exchange.

When is the planned sale date for the Plexus (PLXS) shares under this Form 144?

The Form 144 indicates an approximate sale date of February 3, 2026 for the 4,841 Plexus common shares. This date reflects when the insider expects to begin selling the shares on the NASDAQ, subject to market conditions and Rule 144 requirements.

What is the source of the Plexus (PLXS) shares being sold by Patrick Jermain?

The 4,841 Plexus shares come from restricted stock and performance shares. Specifically, 2,694 shares were acquired as restricted stock on January 25, 2019, and 2,147 shares were acquired as performance shares on November 13, 2024, both directly from the issuer.

Has Patrick Jermain recently sold other Plexus (PLXS) shares before this Form 144?

Yes. Over the prior three months, Patrick Jermain sold 2,000 Plexus common shares on November 11, 2025, generating gross proceeds of $287,070.00. This earlier sale is disclosed alongside the new planned 4,841-share Rule 144 transaction.

Through which broker will the Plexus (PLXS) Form 144 sale be executed?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The filing specifies this broker for selling the 4,841 Plexus common shares on the NASDAQ exchange.